Healthcare Market in India 2020


SKU: 925 Category: Tag:


In terms of revenue and employment generation, healthcare has been one of the biggest industries in India. Kerala is one of the states in India that offers outstanding healthcare facilities.

Market insights:
The healthcare market in India was valued at INR 14.32 Tn in 2019 and is expected to expand at a compound annual growth rate (CAGR) of ~34.04% during the 2020-2025 period, to reach INR 65.51 Tn by 2025. The growth of the market can be attributed to the surge in demand for home healthcare devices, digital healthcare solutions and pharmaceutical products. Rise in the prevalence of chronic diseases, growing investments from public and private investors, and the emergence of advanced technologies like telehealth and telemedicine solutions are some of the major factors propelling the growth of the Indian healthcare market. Relaxation of FDI and increased government expenditure are some of the key factors to drive the healthcare market during the 2016-2020 period. However, inadequate healthcare infrastructure in India and low penetration of health insurance are impeding market growth.

Segment Insights:
The healthcare market in India is segmented into outpatient care centers, hospitals, pharmaceuticals, medical equipment and supplies, diagnostic services, digital healthcare, research and development, medical insurance and medical tourism. As of 2019, the healthcare market was dominated by the hospitals segment, which accounted for about 38.50% of the total market revenue. By 2025, the market share of the hospitals segment is expected to decline by ~10.55% to hold around 27.95% of the overall healthcare market revenue. During the 2020-2025 period, the digital healthcare segment is anticipated to become the fastest growing segment in the market as a result of the self-isolation norms imposed to restrain the spread of COVID-19 and the cost-benefit obtained from using digital healthcare solutions. Other segments of the market which are expected to witness high growth rate during the forecast period are the pharmaceuticals, and medical equipment and supplies segments.

COVID-19 impact analysis:
The outbreak of the contagion, followed by a long-term nationwide lockdown has had a severe impact on the overall healthcare market in India. The market segments that are likely to be positively impacted during the pandemic and the period thereafter are the digital healthcare segment, pharmaceuticals, medical equipment and supplies segment. The medical research and development (R&D) segment and the medical insurance segments are expected to experience a relatively short-term benefit during this crisis period. The medical R&D segment and the insurance segment are some of the least prioritized segments of the Indian healthcare industry and hence, the impact of COVID-19 on these segments are expected plunge with the diminishing effect of the pandemic. Other healthcare segments such as hospitals, medical tourism, and outpatient care centers are witnessing severe downfall in their markets due to the risk of virus transmission from social gatherings and the imposition of the social distancing norms.

Companies covered
• Apollo Hospitals Enterprise Limited
• Aster DM Healthcare Limited
• Cipla Limited
• Dr. Lal PathLabs Limited
• Fortis Healthcare Limited
• Healthcare Global Enterprises Limited
• Narayana Hrudayalaya Limited
• Sun Pharmaceuticals Industries Limited
• Columbia Asia Hospitals Private Limited
• Max Healthcare Private Limited

Additional information


Geography Covered

Date Published



Table of Contents

Chapter 1: Executive summary

Chapter 2: Socio-economic indicators

Chapter 3: Introduction
3.1. Market definition and structure

Chapter 4: Market overview
4.1. India healthcare market – overview
4.1.1. Market size and growth forecast based on value (2018-2025e)
4.1.2. Major health cities in India

Chapter 5: Impact of COVID-19
5.1. Impact of COVID-19
5.2. Companies manufacturing COVID-19 antiviral drugs
5.3. Companies developing vaccines against COVID-19
5.4. Companies developing COVID-19 test kits
5.5. Indian government initiatives against COVID-19
5.6. International relationship development as a result of COVID-19

Chapter 6: Market segmentation
6.1. Healthcare market in India – segmentation
6.1.1. India healthcare market share based on type (2018-2025e)
6.1.2. India outpatient care services market size and growth forecast (2018-2025e)
6.1.3. India hospitals market size and growth forecast (2018-2025e)
6.1.4. India pharmaceuticals market size and growth forecast (2018-2025e)
6.1.5. India medical equipment and supplies market size and growth forecast (2018-2025e)
6.1.6. India diagnostic services market size and growth forecast (2018-2025e)
6.1.7. India digital healthcare market size and growth forecast (2018-2025e)
6.1.8. India medical research and development market size and growth forecast (2018-2025e)
6.1.9. India medical insurance market size and growth forecast (2018-2025e)
6.1.10. India medical tourism market size and growth forecast (2018-2025e)

Chapter 7: Market influencers
7.1. Market drivers
7.2. Market challenges

Chapter 8: Government initiatives
8.1. Government initiatives
8.2. Upcoming healthcare projects in India

Chapter 9: Market trends
9.1. Market trends

Chapter 10: Competitive landscape
10.1. Key players in the market
10.1.1. Apollo Hospitals Enterprise Limited
 Company information
 Business description
 Products/services
 Key people
 Financial snapshot
 Key business segments
 Key geographical segments
Note: Financial data and segment-wise data is available
for public companies only
10.1.2. Aster DM Healthcare Limited
10.1.3. Cipla Limited
10.1.4. Dr. Lal PathLabs Limited
10.1.5. Fortis Healthcare Limited
10.1.6. Healthcare Global Enterprises Limited
10.1.7. Narayana Hrudayalaya Limited
10.1.8. Sun Pharmaceuticals Industries Limited
10.1.9. Columbia Asia Hospitals Private Limited
10.1.10. Max Healthcare Private Limited

Chapter 11: Merger and acquisitions
11.1. Merger and acquisitions

Chapter 12: Funding and investments
12.1. Funding and investments

Chapter 13: Recent developments
13.1. Recent developments

Chapter 14: Appendix
14.1. Research methodology
14.2. About Netscribes
14.3. Disclaimer